MaxCyte Inc is a life sciences company focused on advancing the discovery, development, and commercialization of next-generation cell therapies. It uses its proprietary cell engineering technology platform to support biotechnology and pharmaceutical customers in cell therapy, gene editing, immuno-oncology, and biologic development. It operates in one segment: cell engineering technology, which generates revenue mainly from product sales, licenses, research and clinical license fees, and program-related revenues as its SPL customers achieve development and regulatory milestones. Its platform, the ExPERT Platform, is based on Flow Electroporation technology designed to efficiently and safely modify human cells with high efficiency, low cytotoxicity, and scalability for clinical use.

What symbol and exchange does Maxcyte shares trade?

Maxcyte trades on the NASDAQ stock market under the symbol MXCT.

What is Maxcyte stock price doing today?

As of October 28, 2026, MXCT stock price climbed to $1.71 with 1,697,560 million shares trading.

What is Maxcyte's Beta?

MXCT has a beta of 1.31, meaning it tends to be more sensitive to market movements. MXCT has a correlation of 0.05 to the broad based SPY ETF.

How much is Maxcyte worth?

MXCT has a market cap of $176.48 million. This is considered a Micro Cap stock.

How much money does Maxcyte make?

Last quarter Maxcyte reported $7 million in Revenue and -$.08 earnings per share. This beat revenue expectation by $797,080 and exceeded earnings estimates by $.02.

What is the highest and lowest price Maxcyte traded in the last 3 year period?

In the last 3 years, MXCT traded as high as $5.55 and as low as $.64.

What are the top ETFs holding Maxcyte?

The top ETF exchange traded funds that MXCT belongs to (by Net Assets): VTI, VXF, VHT, BUSM.

Is Maxcyte (MXCT) a good investment?

MXCT has underperformed the market in the last year with a return of +10.3%, while SPY returned +13.5%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in MXCT shares. However, MXCT has outperformed the market in the last 3 month and 2 week periods, returning +62.9% and +36.8%, while SPY returned +4.5% and +0.4%, respectively. This indicates MXCT has been having a stronger performance recently.

What are the support and resistance levels for Maxcyte (MXCT)?

MXCT support price is $1.46 and resistance is $1.62 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MXCT shares will trade within this expected range on the day.